This revision of the 2005 British Association for Psychopharmacology guidelines for the
evidence-based pharmacological treatment of anxiety disorders provides an update on key …

Summary Selective serotonin [5‐hydroxytryptamine (5‐HT)] reuptake inhibitors (SSRIs) and
the 5‐HT noradrenaline reuptake inhibitor, venlafaxine, are mainstays in treatment for …

Objective: Use of antidepressants has been reported to cause considerable weight gain.
The aim of this study was to assess the risk of diabetes mellitus associated with …

Patients with uncontrolled hypertension are at risk for cardiovascular complications. The
majority of them suffers from unidentified forms of hypertension and a fraction has so-called …

Extended release of drugs is extremely essential for patients who require medicinal
treatment round the clock. Depressed patients are one of such patients who suffer from …

OBJECTIVE: The objective of the study was to assess the efficacy and safety of
desvenlafaxine (administered as desvenlafaxine succinate) for menopausal vasomotor …

Migraine and metabolic syndrome are highly prevalent and costly conditions. The two
conditions coexist, but it is unclear what relationship may exist between the two processes …

The objective of the present study is to develop montmorillonite (Mt) based PLGA
nanocomposites for oral and controlled release carrier for an antidepressant drug …

Background The aim of this study was to explore the relationships between depressive
symptoms and health-related quality of life (HRQOL) measurements for inpatients with major …

Understanding and addressing somatic symptoms are complex in older adults, who have
more comorbid medical illnesses. This article describes a systematic review of the literature …